HR Execs on the Move

WorkCompEDI

www.workcompedi.com

 
WorkCompEDI, Inc. is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.workcompedi.com
  • 85 W Algonquin Rd Ste 410
    Arlington Heights, IL USA 60005
  • Phone: 800.297.6906

Executives

Name Title Contact Details

Similar Companies

Organ Recovery Systems

Organ Recovery Systems is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

North Coast Health Ministry

North Coast Health Ministry is a Lakewood, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wimbledon Health Partners

Wimbledon Health Partners formed in 2013 to meet the need for on-site diagnostic testing at physicians’ offices. The industry leader, Wimbledon Health Partners provides physicians with state-of-the-art, in-office testing to detect circulatory conditions using vascular ultrasound and electro- and echocardiography. Nerve conduction velocity testing is also used to support diagnosis of problems related to the nervous and muscular systems. Wimbledon Athletics, the newest division of Wimbledon Health Partners, is pioneering the way for high schools, colleges and universities to test students for unsuspected heart abnormalities to help minimize sudden cardiac death among young athletes.

Markwins International Corporation

FOR ALMOST TWO DECADES, MARKWINS INTERNATIONAL has been providing expertly designed cosmetic and beauty care collections.

Voyager Therapeutics

Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.